DGAP-News: 4SC Presents Update on Phase II SHELTER trial with Oral Pan-HDAC Resminostat at the 2011 Gastrointestinal …

DGAP-News: 4SC Presents Update on Phase II SHELTER trial with Oral Pan-HDAC Resminostat at the 2011 Gastrointestinal … DGAP-News: 4SC AG / Key word(s): Miscellaneous4SC Presents Update on Phase II SHELTER trial with Oral Pan-HDACResminostat at the 2011 Gastrointestinal Cancer Symposium21.01.2011 / 07:30Planegg-Martinsried, Germany, 21 January, 2011- 4SC … Read more on wallstreet:online AG Tabloid tale UK phone-hacking row has long way to run Read more on BBC News